Cramer’s Recommendations
On CNBC’s “Mad Money Lightning Round,” Jim Cramer expressed his affinity for Realty Income O and advised investors to stick with it. “It’s a very steady story,” he noted.
When asked about ImmunoGen, Inc. IMGN, he made it explicit that the property is now under AbbVie’s control and swiftly moved on.
Cramer declared that he is not interested in Ramaco Resources, Inc. METC and added, “Let it go up without me.”
Don’t forget to check out our premarket coverage here.
The “Mad Money” host conveyed his skepticism about Bitfarms Ltd. BITF, describing it as purely speculative.
Addressing Micron Technology, Inc. MU, Cramer predicted that the stock could stagnate or regress to the high seventies.
Cramer opined that Coherent Corp. COHR is “a little too expensive.”
In contrast, he lauded GE HealthCare Technologies Inc. GEHC as “ridiculously cheap” and commended its performance, stating, “I think it’s doing so many great things.”
Expressing bewilderment at the valuation of TKO Group Holdings, Inc. TKO, he conveyed his approval for Arm Holdings plc ARMH, praising CEO Rene Haas for his stellar leadership.
Moreover, he noted that on Nov. 8, the chipmaker will release its first earnings report since its initial public offering in September.
Concluding, Cramer revealed his disinterest in Teva Pharmaceutical Industries Limited TEVA.
Price Movement
Following Cramer’s remarks, Teva’s shares rose by 4.1% to $11.33, yet Arm Holdings saw its stock price tumble by 2% to $67.05 on Friday. Similarly, TKO dropped by 0.3% to finish at $78.63, while GE HealthCare experienced a meager 0.1% gain to reach $76.62 during the same session. Coherent shares increased by 1.4% to settle at $41.17, and Micron climbed by 0.9% to close at $83.45. Conversely, Bitfarms plummeted by 7.2%, and Ramaco Resources declined by 1.2%. ImmunoGen shares inched up by 0.4%, and AbbVie also experienced a 0.4% rise on Friday. Realty Income witnessed a 0.4% increase, closing at $57.92 during the session.
Now Read This: How To Earn $500 A Month From Conagra Brands Stock Following Latest Earnings Report.